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Infracarpal Upper Extremity Arterial Bypass: Is it Worth it?
Philip S K Paty, Benjamin B Chang, R Clement Darling, III, Sean P Roddy,
Manish Mehta, Paul B Kreienberg, Kathleen J Ozsvath, Yaron Sternbach,
John B Taggert, Dhiraj M Shah. Albany Medical College, Albany, NY
Objectives: Patients presenting with digital ischemia and arterial
occlusion distal to the wrist are a disadvantaged population with renal
failure, collagen vascular disease and hypercoaguable states and difficult
technical options for revascularization. A nonaggressive stance to treat-
ment in these patients often leads to significant digit/hand loss and thus
we have approached these patients aggressively in order to try to improve
limb salvage.
Methods: A retrospective review of all upper extremity bypasses per-
formed to arteries distal to the wrist was performed. All patients were
evaluated with biplanar arteriography. Patients with hypercoaguable states
and rheumatoid arthitides/collagen vascular disease (RA) were medically
evaluated prior to operation. Postoperative surveillance was performed with
PVR and Duplex scan. Vein bypasses were performed in all cases. Patency
was computed according to life table methods.
Results: Between 1993 and 2008, 40 bypasses were performed in 34
patients for digital gangrene (20), rest pain (13) and ulcer (5). There were 19
males and 15 females. Patient risk factors included diabetes (17), active smoking
(17), hypertension (13), hyperlipidemia (8), Coronary disease (10) and renal
failure (18). Documented hypercoaguable states and RA were present in four
and 12 patients, respectively. Outflow arteries included distal radial (29), distal
ulnar (1), palmar arch (7) and common digital arteries (3). Venous conduit
included saphenous and cephalic veins in reversed (34), nonreversed (3) and
spliced (3) configuration. There was no operativemortality. Digital amputation
was performed in 19patients for gangrene andminor debridement in 4 patients.
There were 5 bypass occlusions all of which occurred in the first year. Cumula-
tive patency from this point on was 84% (mean follow up: 22 months (range:
1-184 months)). Cumulative survival was 57% at 2 years and 26% at 5 years.
Conclusions: Arterial bypass in patients with infracarpal upper extrem-
ity arterial disease is challenging but may be achieved with excellent patency.
Digital amputation is often required. Long term survival in these patients is
limited and perioperative management of patient risk factors important.
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Natural History of Mesenteric Artery Stent Restenoses and Clinical
and Anatomic Predictors for Re-intervention in Patients with Chronic
Mesenteric Ischemia
Gustavo S. Oderich, Thanila A. Macedo, Rafael Malgor, Joseph J. Ricotta,
II, Terri Vrtiska, Audra A. Duncan, Manju Kalra, Peter Gloviczki. Mayo
Clinic, Rochester, MN
Objectives: To determine the natural history, clinical and anatomical
predictors of mesenteric artery stent (MAS) restenosis in patients with
chronic mesenteric ischemia (CMI).
Methods: The clinical data of 102 patients treated with 127 MAS for
CMI was entered into a prospective database (2001-2006). Data was
reviewed in 87 patients (57 female, 30 male; median age 77 years) with
imaging follow up 3months (mean 2822 months). Pre-procedure com-
puted tomography angiography (CTA) with centerline of flow analysis and
biplanar angiography were reviewed to determine anatomic measurements.
Mesenteric restenosis was defined as60% restenosis by CTA, angiography
or duplex ultrasound. Univariate and logistic regression analysis was per-
formed to identify factors associated with restenosis.
Results: There were 71 SMA and 35 celiac stents. Forty-seven patients
(54%) developed restenosis. Symptomatic restenoses in 17 patients (13 chronic,
4 acute) were treated with re-intervention (12 endovascular, 3 open) in all
except 2 patients who died of unrelated causes. Asymptomatic restenoses in 30
patients (23 with angiographic confirmation) were followed for 3025
months: 4 (13%) developed symptoms (3 chronic, 1 acute) and 8 had re-
interventions (4 prophylactic). There were no deaths associated with re-inter-
ventions and82patients (94%) referred symptom improvement at their last visit.
Freedom from restenosis, recurrence and re-intervention at 3-years was 356%,
657% and 657%. Primary and secondary patency rates were 607% and
865% at same intervals. There were more (P.05) restenoses in female
patients (63% vs 37%), and those with occlusions (100% vs 46%), severe
calcification (80% vs 40%), longer lesions (30mm, 71% vs 52%) and vessel
diameter 7mm (63% vs 21%). Occlusions and severe calcification were inde-
pendently associated with higher risk of restenosis (P.01).
Conclusion: MAS restenoses occur in approximately half of the pa-
tients, of which half develop recurrent mesenteric ischemia. Our results
support a conservative approach for asymptomatic restenosis and a policy ofearly re-intervention in the presence of symptoms. Patients with longer or
calcified lesions and those with residual post-procedure stenosis have the
highest re-intervention rates.
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Visceral Artery Duplex Ultrasound Velocity Criteria for Instent Steno-
sis Following Mesenteric Artery Stenting: Validated with Arteriogra-
phy
Christopher L Stout1, Cory A Messerschmidt2, Greg C Schmieder1, Albert
I Richardson, II1, Gordon K Stokes1, Jean M Panneton1. 1Division of
Vascular Surgery, Eastern Virginia Medical School, Norfolk, VA; 2Eastern
Virginia Medical School, Norfolk, VA
Objectivs: The number of patients undergoing endovascular therapy for
mesenteric ischemia is rapidly increasing. The accuracy of mesenteric duplex
ultrasound (DUS) has not been established for the prediction of in-stent
restenosis (ISR) of the celiac (CA) or superior mesenteric artery (SMA). The
purpose of this study is to determineDUS velocity criteria formesenteric stents.
Methods: A retrospective review all consecutive patients that under-
went endovascular stenting from July 2004 to July 2008 was completed.
The angiography (DSA) and DUS were performed within three months of
each other to be considered paired measurements. Standard statistical anal-
ysis was performed.
Results: There were 53 SMA and 17 CA ultrasound and angiography
pairs. CA analysis of receiver operator curves (ROC) showed no discrimina-
tion betweenDUS and greater than 70% stenosis onDSA, p0.65. Using all
CA paired studies, a velocity of 226 cm/s has a sensitivity of 1 and specificity
of 0.33 and a velocity of 449 cm/s has a sensitivity of 0.50 and specificity of
0.87 (Table 1). SMA analysis of ROC curves showed an AUC of 0.74
between DUS and greater than 70% stenosis on DSA, p0.007. Using all
paired SMA studies, a velocity of 302 cm/s has a sensitivity of 1 and
specificity of 0.5 and a velocity of 645 cm/s has a sensitivity of 0.27 and
specificity of 1 (Table 1).
Conclusions: Duplex ultrasound grading of stent restenosis for mes-
enteric vessels has not been validated. Superior mesenteric artery stent
stenosis can be diagnosed with good sensitivity and PPV using DUS. This
data can help guide the decision to perform arteriography for specific DUS
velocities of mesenteric stents.
Table 1. Celiac Artery ROC Analysis
DUS (cm/s) Sensitivity Specificity PPV NPV
226 1 0.33 0.17 1.00
263 0.50 0.40 0.10 0.86
337 0.50 0.47 0.11 0.88
350 0.50 0.53 0.13 0.90
365 0.50 0.67 0.17 0.91
425 0.50 0.73 0.20 0.92
449 0.50 0.87 0.33 0.93
460 0.50 0.93 0.50 0.93
Table 2. Superior mesenteric artery ROC analysis
DUS (cm/s) Sensitivity Specificity PPV NPV
302 1 0.48 0.23 1
320 1 0.50 0.23 1
335 0.86 0.50 0.21 0.96
343 0.86 0.52 0.21 0.96
362 0.71 0.52 0.19 0.92
375 0.71 0.57 0.20 0.93
403 0.57 0.65 0.20 0.91
417 0.43 0.67 0.17 0.89
462 0.43 0.76 0.21 0.90
482 0.43 0.80 0.25 0.90
506 0.43 0.85 0.30 0.91
525 0.43 0.87 0.33 0.91
549 0.43 0.91 0.43 0.91
609 0.27 0.98 0.67 0.90
645 0.27 1 1 0.90
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In-Hospital Mortality of Open Thoracoabdominal Aortic Aneurysm
Repair in the United States Prior to Widespread Use of Hybrid and
Endovascular Branched Techniques
Gustavo S. Oderich1, Eric B. Rosero2, Joseph J. Ricotta, II1, Peter Glovic-
zki1, Thomas C. Bower1, Audra A. Duncan1, Manju Kalra1, Carlos Tima-
ran2. 1Mayo Clinic, Rochester, MN; 2University of Texas Southwestern,
Dallas, TX
Objectives: Hybrid debranching procedures and branched stent grafts
have been proposed as alternative treatments to lower the morbidity and
mortality associated with open thoracoabdominal aortic aneurysm (TAAA)
repair. The purpose of this study was to determine in-hospital mortality and
factors predicting in-hospital death after open repair of TAAA in the United
States (US) prior to the widespread use of new technologies.
Methods: The Nationwide Inpatient Sample (NIS) identified open
repair procedures for non-ruptured TAAA during the years 2000-2006. Risk
stratification was based on the Charlson comorbidity index (CCI), which
provides aggregate measures of 18 clinical parameters. Weighted logistic
regression analyses were used to determine independent predictors of in-
hospital mortality and complications taking into account the NIS sample
design.
Results: There were 5,776 open repairs for non-ruptured TAAA
performed during the 7-year period. The median age was 70 years and 43%
were women. Major comorbidities included hypertension (56%), chronic
pulmonary disease (35%), chronic renal insufficiency (11%) and prior myo-
cardial infarction (8%). The in-hospital mortality was 16%. Postoperative
complications included acute renal insufficiency (25%), respiratory insuffi-
ciency (10%), acute mesenteric ischemia (3%) and myocardial infarction
(3%). Acute renal insufficiency (ARI) was the main independent predictor of
in-hospital mortality (odds ratio [OR], 3.5; 95% confidence interval
[95%CI], 3.0-4.1), and independent factors associated with higher postop-
erative ARI rates were age, CCI, chronic renal insufficiency, rural and
non-teaching hospital. In addition to ARI, logistic regression analysis iden-
tified age, male gender, chronic renal insufficiency, CCI, and rural and
non-teaching hospital location as independent predictors for in-hospital
death.
Conclusions: Open surgical treatment of TAAAs carries high in-
hospital mortality (16%) in the US. Renal insufficiency, age, gender, higher
Charlson comorbidity index, and rural and non-teaching hospital are impor-
tant predictors of in-hospital death. These benchmark data provide a stan-
dard for comparison against which surgeons can compare their own results
with newer hybrid and endovascular branched techniques proposed to treat
TAAA.
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Malrotation and Bending of Multi-Branched Thoracoabdominal Stent
Grafts
Ki-Hyuk Park1,2, Jade S Hiramoto1, Linda M Reilly1, Timothy A M
Chuter1. 1UCSF, San Francisco, CA; 2Daegu Catholic University School of
Medicine, Daegu, Republic of Korea
Objective: To assess the accuracy of thoracoabdominal stent graft
deployment and the effect of stent graft orientation on angulation of the
visceral branches.
Method: Multi-branched stent grafts were assembled in-situ, using
covered stents to connect short, caudally-directed cuffs on the stent graft
with the corresponding visceral arteries. Measurements of actual cuff orien-
tation (ACO), actual vessel orientation (AVO), and longitudinal branch
length (LBL) were based on 3-dimensional analysis (TeraRecon) of postop-
erative CT scans. The actual orientation of the cuff (ACO) was compared
with the planned orientation (PCO) to assess malorientation (ACO-PCO).
The ACO was also compared with AVO to assess branch angulation in
trans-axial (ACO-AVO) and longitudinal (LBA) planes. The ACO-PCO of
the CA cuff was compared with the ACO-PCO of distal cuffs to assess
twisting between cuffs.
Results: Between Nov 2005 and Dec 2008, 38 patients underwent
multi-branched endovascular aortic aneurysm repair with a total of 141
branches to the visceral arteries. Small degrees of malorientation (ACO-
PCO) were common, but severe malorientation (45 degrees) was rare.The cuff-bearing portion of the stent graft usually rotated as a single unit.
Only one patient had  30 degrees of twisting between the CA and SMA
cuffs and only 4 had 30 degrees between the CA and LRA. For any given
degree of malrotation, higher LBL resulted in lower LBA. 91% of visceral
arteries lay within a vertical 60 degree-wide arc (LBA 2), centered on the
outer orifice of the corresponding cuff. Although the mean values of PCO
and AVOwere similar, individual values often differed because PCO referred




(Meansd deg) LBL (mm)
LBA
(Meansd deg)
CA 18.111.6 18.911.6 22.210.9 15.311.0
SMA 18.211.4 20.315.5 19.99.4 16.212.2
RRA 16.912.3 17.913.4 23.98.9 14.414.4
LRA 20.513.4 21.215.8 23.78.9 13.08.6
All Branches 18.412.1 19.814.0 22.39.6 14.811.7
Percent 30 15.9% 23.2% 17.2% 9.0%
Percent 45 3.6% 5.8% 3.0% 2.2%
All 141 branches were inserted as planned. None have migrated, discon-
nected, or kinked.
Conclusions: The branches of a thoracoabdominal stent graft bend to
accommodate the malorientation and eccentric position of the trunk, but
these angles do not compromise the feasibility or stability of branch implan-
tation.
Author Disclosures: K. Park, None; J.S. Hiramoto, None; L.M. Reilly,
None; T.A.M. Chuter, Cook Medical, Inc.; Cook Medical, Inc.; Cook
Medical, Inc.
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Early Outcomes Following Endografting or Open Surgery for Thoracic
Aortic Pathology: Data From the National Surgical Quality Improve-
ment Project
David A. Peterson, Hardeep Ahluwalia, Mihir Gandhi, Sonny Tucker, Leila
Mureebe, Cynthia K. Shortell. Duke University Medical Center, Durham,
NC
Background: Literature comparing thoracic endografting (TEVAR)
to OPEN surgery for thoracic aortic pathology includes reports from single
institutions or industry-maintained registries focusing on aneurysmal dis-
ease. We hypothesized that early outcomes are improved in patients under-
going TEVAR rather than OPEN repair of thoracic aortic pathology, based
on independent, multicenter data.
Methods: Patients who underwent TEVAR or OPEN repair of tho-
racic aortic pathology (aneurysms, ruptured aneurysms, dissections or trau-
matic injuries) from 2006 to 2008 were identified in the American College
of Surgeons National Surgical Quality Improvement Project (ACS-NSQIP)
database. Data collection included: 30 day mortality; confounding variables
(age, gender, American Society of Anesthesiologists class, diabetes, serum
albumin, renal function, and cardiopulmonary status); intra- and post-
operative outcomes. Inferential statistics and generalized linear models were
used to compare TEVAR and OPEN outcomes.
Results: Two hundred sixty-nine (N269) patients underwent repair
of thoracic aortic pathology (TEVAR: 139 vs. OPEN: 130). Two hundred
and seven (77%) patients had intact aneurysms, 42 (16%) had dissections or
traumatic injuries, and 20 (7%) had ruptured aneurysms. Bivariate analysis
revealed no significant differences in 30 day mortality (TEVAR: 9 [4%] vs.
Open: 11 [5%]). Adjusted outcomes demonstrated significant decreases
(p0.05) in TEVAR: length of stay (median (med) TEVAR: 6.5 days, 95%
confidence interval (CI): 5.2, 7.8 vs. OPEN: 14.7 days, CI: 13.2, 16.2);
operative time (med: 141 minutes, CI: 117, 165 vs. 355 minutes, CI: 348,
401); occurrence of post-operative pneumonia (N11 [8%] vs. 47 [36%],
odds ratio (OR): 0.16, CI: 0.06, 0.42 ); reintubation (N11 [8%] vs. 25
[19%], OR: 0.21, CI: 0.06, 0.68 ); and acute renal failure (N4 [3%] vs. 16
[12%], OR: 0.11, CI: 0.02, 0.64 ).
Conclusions: Among patients undergoing repair of thoracic aortic
pathology, TEVAR is associated with similar mortality but decreased early
morbidity, operative time, and length of stay when compared to OPEN
surgery. These findings suggest that broader adoption of TEVAR for tho-
racic aortic disease will lead to reductions in early morbidity, operative time,
and length of stay associated with repair.
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